Abstract:Transdermal Drug Delivery Systems (TDDS) show significant advantages over other forms of drug application. Despite their clinical use for decades, these drug delivery devices have yet to reach their full potential. While polymer matrices are most commonly used as transdermal patches so far, inorganic carriers like mesoporous silica membranes offer several advantages, including chemical stability and their tunable porous system, with adjustable pore sizes, pore volumes and surface chemistries. In this study, we chemically modified high and low porosity mesoporous silica membranes by post-synthetic methods and compared the effects of different surface modifications on loading efficacies and release profiles of different pharmacologically relevant drugs with different chemical properties. Drug loading capacities and release profiles were substantially affected by pore structure and surface modifcations with strongly acidic SO 3 H groups or hydrophobic methyl groups, while weakly acidic COOH groups or nitrile groups showed little effects. SO 3 H modification of low porosity (LP) membranes led to markedly increased loading capacity and a more sustained release profile of anastrozole. The latter was also observed for xylazine, but associated with lesser drug loading. Likewise, the SO 3 H modification also slowed down the release of imiquimod or flunixin. Increasing LP membrane hydrophobicity by methyl modification essentially abolished anastrozole drug loading. In high porosity (HP) membranes, effects of chemical surface modifications were overall weaker. This led to particularly slow anastrozole or xylazine release profiles from methyl-modified membranes. Biocompatibility studies showed some cell-inhibitory effects of CN functionalization, but full biocompatibility of SO 3 H functionalized membranes as indicated by efficient cell attachment and high viability. Both parameters, pore structure and chemical surface modifcations, drug-dependently affect drug loading and release properties. Since they can be precisely fine-tuned in mesoporous silica membranes, this allows for the development of optimized TDDS providing high drug loading and the desired release profile of a given drug. Our results presented here indicate that the SO 3 H modification is particularly useful in this regard. Graphical abstract Download : Download high-res image (211KB) Download : Download full-size image

Effect of Surface Property on the Release and Oral Absorption of Solid Sirolimus-Containing Self-microemulsifying Drug Delivery System

Sirolimus Solid Self-Microemulsifying Pellets: Formulation Development, Characterization and Bioavailability Evaluation.

Oral Bioavailability and Lymphatic Transport of Pueraria Flavone-Loaded Self-Emulsifying Drug-Delivery Systems Containing Sodium Taurocholate in Rats.

Solid Self-Nanoemulsifying Cyclosporine A Pellets Prepared by Fluid-Bed Coating: Stability and Bioavailability Study

Correction to: Effect of Surface Property on the Release and Oral Absorption of Solid Sirolimus-Containing Self-Microemulsifying Drug Delivery System

Surface PEGylation of Mesoporous Silica Materials Via Surface-Initiated Chain Transfer Free Radical Polymerization: Characterization and Controlled Drug Release.

Co-delivery of honokiol, a constituent of Magnolia species, in a self-microemulsifying drug delivery system for improved oral transport of lipophilic sirolimus.

Studies on a new carrier of trimethylsilyl-modified mesoporous material for controlled drug delivery

Lipids-based Nanostructured Lipid Carriers (nlcs) for Improved Oral Bioavailability of Sirolimus.

Development of Silymarin Self-Microemulsifying Drug Delivery System with Enhanced Oral Bioavailability

Direct Surface Grafting of Mesoporous Silica Nanoparticles with Phospholipid Choline-Containing Copolymers Through Chain Transfer Free Radical Polymerization and Their Controlled Drug Delivery

Silymarin Glyceryl Monooleate/Poloxamer 407 Liquid Crystalline Matrices: Physical Characterization and Enhanced Oral Bioavailability

Chemical surface modification of mesoporous SiO 2 -based membranes for fine-tuning of drug loading and release properties

Self-microemulsifying drug-delivery system for improved oral bioavailability of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol: preparation and evaluation

Improved Oral Bioavailability and Hypolipidemic Effect of Syringic Acid via a Self-microemulsifying Drug Delivery System

Formulation and Evaluation of a Self-Microemulsifying Drug Delivery System of Raloxifene with Improved Solubility and Oral Bioavailability

The effect of polymeric binder type and concentration on flow and dissolution properties of SMEDDS loaded mesoporous silica-based granules

Enhanced Bioavailability of Silymarin by Self-Microemulsifying Drug Delivery System

Influence of pore size and surface area of mesoporous silica materilas (MCM-41 and KIT-6) on the drug loading and release

Self-Microemulsion Technology for Water-Insoluble Drug Delivery

Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery